«SGLT2i pharmacological treatment in type 2 diabetes mellitus control and its underlying obesity», Rev Port Med Geral Fam, vol. 40, n.º 2, pp. 148–56, abr. 2024, doi: 10.32385/rpmgf.v40i2.13647.